This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
莎拉球
副总统 & Lead Scientific/Epidemiology Advisor
概述
莎拉球, 镜头分割, MS, 英里每小时, is a 副总统 for Clinical Research and Lead Scientific/Epidemiology Advisor for 趣赢平台’s Health Sector. She is an epidemiologist who is passionate about the innovative design and implementation of clinical research, developing creative solutions for complex data collection, and ensuring the synthesis and timely dissemination of research findings. With a background in maternal and child health and epidemiology, combined with more than a decade of experience in influenza and other respiratory diseases, her experience spans epidemiologic research, clinical study implementation, and program evaluation.
As Lead Scientific/Epidemiology Advisor, Ball is responsible for envisioning and expanding research capabilities (human, 方法论的, and technological) across 趣赢平台’s Health Sector, developing evidence of the validity and utility of 趣赢平台-led research products, and communicating with scientific communities concerning our competencies and scientific offerings. In addition to this work, she currently oversees a large electronic health record network examining 新型冠状病毒肺炎 vaccine effectiveness and has planned and implemented several multisite epidemiologic studies to examine vaccine effectiveness among high-risk populations.
教育
- 镜头分割, Maternal and Child Health, Harvard School of 公共卫生
- MS, Maternal and Child Health, Harvard School of 公共卫生
- 英里每小时, Epidemiology and Biostatistics/Social and Behavioral Health, Boston University School of 公共卫生
- BA, Psychology, Hamilton College
Areas of Expertise
Clinical Research 孕产妇健康 公共卫生 Biostatistics and Epidemiology Epidemiologic Studies主题
新型冠状病毒肺炎-
的角度来看
The 趣赢平台 Team Behind VISION’s Success2024年4月
The VISION Vaccine Effectiveness Network, launched by the Centers for Disease Control and Prevention (CDC) in 2020, spurred a monumental shift in vaccine assessment, 指导……
-
的角度来看
VISION Vaccine Effectiveness Network: Why It Succeeded2023年9月
With the emergency phase of the 新型冠状病毒肺炎 pandemic behind us, interest has grown in understanding why the VISION Vaccine Effectiveness (VE) Network, launched in 2020…
-
Expert Interview
Infectious Respiratory Diseases: What Have We Learned From 新型冠状病毒肺炎?2023年7月
With the emergency phase of the 新型冠状病毒肺炎 pandemic at an end, questions regarding what we’ve learned from the pandemic about tracking and reducing the spread of respiratory diseases are…